HeartBeam Inc. (NASDAQ: BEAT)

medical devices

About

HeartBeam, Inc. is a medical technology company based in Santa Clara, California, focused on improving the detection and monitoring of cardiac conditions. Founded in 2015, HeartBeam has developed a cable-free, credit card-sized device that captures electrocardiogram (ECG) signals from three different directions, synthesizing them into a 12-lead ECG equivalent. This innovative technology allows for portable, real-time cardiac monitoring outside of traditional healthcare settings, enabling physicians to assess patients remotely. The company's flagship product, HeartBeam AIMIGo, combines the portable ECG device with cloud-based diagnostic software for early detection of heart attacks and arrhythmias. The system is FDA cleared for arrhythmia assessment and is expected to receive further regulatory clearance for its 12-lead ECG synthesis software by the end of 2025. HeartBeam's solutions are designed for patients needing continuous or episodic cardiac monitoring, providing healthcare providers with actionable data to support timely clinical decisions.

Technologies

MaropostOutlookMicrosoft Office 365Amazon AWSWebflowApacheMobile FriendlyGoogle Font APIGoogle Tag ManagerVimeoIoTRemoteAI

Keywords

heart health & cardiac diagnostic solutionmedical equipment manufacturinghigh-accuracy ecg algorithmsmedical device innovationb2cremote arrhythmia detectionpatient-centered ecghealthcare equipment & suppliesnon-invasive cardiac devicecloud-based ecg storageclinical trial datamedical device patentsd2cpatient use at homedigital health platformpersonalized cardiac careai deep learningcable-free ecgremote patient monitoringremote diagnosticsdigital health ecosystemecg cloud transferheart rhythm analysiswearable ecg technologyai in cardiology3d ecg signalsdigital healthdigital health patent portfolioheart health insightsfda cleared ecg system

Location

2118 Walsh Ave, Santa Clara, California, United States, 95050-2512

Related Companies

Companies in the same industry